245 related articles for article (PubMed ID: 29084790)
1. Targeted Adherence Intervention to Reach Glycemic Control with Insulin Therapy for patients with Diabetes (TARGIT-Diabetes): rationale and design of a pragmatic randomised clinical trial.
Lewey J; Wei W; Lauffenburger JC; Makanji S; Chant A; DiGeronimo J; Nanchanatt G; Jan S; Choudhry NK
BMJ Open; 2017 Oct; 7(10):e016551. PubMed ID: 29084790
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.
Lauffenburger JC; Lewey J; Jan S; Makanji S; Ferro CA; Krumme AA; Lee J; Ghazinouri R; Haff N; Choudhry NK
JAMA Netw Open; 2019 Mar; 2(3):e190657. PubMed ID: 30874782
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
[TBL] [Abstract][Full Text] [Related]
5. Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial.
Alfian SD; Abdulah R; Denig P; van Boven JFM; Hak E
BMJ Open; 2020 Jan; 10(1):e034507. PubMed ID: 31911526
[TBL] [Abstract][Full Text] [Related]
6. The Medicines Advice Service Evaluation (MASE): a randomised controlled trial of a pharmacist-led telephone based intervention designed to improve medication adherence.
Lyons I; Barber N; Raynor DK; Wei L
BMJ Qual Saf; 2016 Oct; 25(10):759-69. PubMed ID: 26755665
[TBL] [Abstract][Full Text] [Related]
7. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
Wishah RA; Al-Khawaldeh OA; Albsoul AM
Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
[TBL] [Abstract][Full Text] [Related]
8. Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trial.
Lauffenburger JC; Ghazinouri R; Jan S; Makanji S; Ferro CA; Lewey J; Wittbrodt E; Lee J; Haff N; Fontanet CP; Choudhry NK
PLoS One; 2019; 14(4):e0214754. PubMed ID: 30939143
[TBL] [Abstract][Full Text] [Related]
9. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes.
Huo X; Spatz ES; Ding Q; Horak P; Zheng X; Masters C; Zhang H; Irwin ML; Yan X; Guan W; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
BMJ Open; 2017 Dec; 7(12):e018302. PubMed ID: 29273661
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic trial.
Lauffenburger JC; Lewey J; Jan S; Nanchanatt G; Makanji S; Ferro CA; Sheehan J; Wittbrodt E; Morawski K; Lee J; Ghazinouri R; Choudhry NK
Contemp Clin Trials; 2017 Aug; 59():57-63. PubMed ID: 28571997
[TBL] [Abstract][Full Text] [Related]
11. Multicomponent provider-patient intervention to improve glycaemic control in Medicaid-insured pregnant individuals with type 2 diabetes: clinical trial protocol for the ACHIEVE study.
Venkatesh KK; Joseph JJ; Swoboda C; Strouse R; Hoseus J; Baker C; Summerfield T; Bartholomew A; Buccilla L; Pan X; Sieck C; McAlearney AS; Huerta TR; Fareed N
BMJ Open; 2023 May; 13(5):e074657. PubMed ID: 37164461
[TBL] [Abstract][Full Text] [Related]
12. Study investigating the impact of pharmacist involvement on the outcomes of diabetes medication therapy adherence program Malaysia.
Lim PC; Lim K; Embee ZC; Hassali MA; Thiagarajan A; Khan TM
Pak J Pharm Sci; 2016 Mar; 29(2):595-601. PubMed ID: 27087103
[TBL] [Abstract][Full Text] [Related]
13. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus.
Nazir SUR; Hassali MA; Saleem F; Haque N
Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877
[TBL] [Abstract][Full Text] [Related]
14. REinforcement learning to improve non-adherence for diabetes treatments by Optimising Response and Customising Engagement (REINFORCE): study protocol of a pragmatic randomised trial.
Lauffenburger JC; Yom-Tov E; Keller PA; McDonnell ME; Bessette LG; Fontanet CP; Sears ES; Kim E; Hanken K; Buckley JJ; Barlev RA; Haff N; Choudhry NK
BMJ Open; 2021 Dec; 11(12):e052091. PubMed ID: 34862289
[TBL] [Abstract][Full Text] [Related]
15. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC
Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750
[TBL] [Abstract][Full Text] [Related]
16. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.
Odegard PS; Goo A; Hummel J; Williams KL; Gray SL
Ann Pharmacother; 2005 Mar; 39(3):433-40. PubMed ID: 15701763
[TBL] [Abstract][Full Text] [Related]
17. Structured, intensive education maximising engagement, motivation and long-term change for children and young people with diabetes: a cluster randomised controlled trial with integral process and economic evaluation - the CASCADE study.
Christie D; Thompson R; Sawtell M; Allen E; Cairns J; Smith F; Jamieson E; Hargreaves K; Ingold A; Brooks L; Wiggins M; Oliver S; Jones R; Elbourne D; Santos A; Wong IC; O'Neill S; Strange V; Hindmarsh P; Annan F; Viner R
Health Technol Assess; 2014 Mar; 18(20):1-202. PubMed ID: 24690402
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care.
Salvo MC; Brooks AM
Ann Pharmacother; 2012 Jan; 46(1):29-34. PubMed ID: 22202497
[TBL] [Abstract][Full Text] [Related]
19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
20. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
Choudhry NK; Isaac T; Lauffenburger JC; Gopalakrishnan C; Lee M; Vachon A; Iliadis TL; Hollands W; Elman S; Kraft JM; Naseem S; Doheny S; Lee J; Barberio J; Patel L; Khan NF; Gagne JJ; Jackevicius CA; Fischer MA; Solomon DH; Sequist TD
JAMA Intern Med; 2018 Sep; 178(9):1182-1189. PubMed ID: 30083727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
